Ondansetron HCL 4 MG tablet 500S
Ended Awarded Last action
- Contract number
- SPE2DR26F9KK8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,475
Award facts
- Contract value 100% obligated
- $25,474.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25.5K delivery order to AmerisourceBergen Drug Corp on January 9, 2026, for the supply of 500 tablets of Ondansetron HCL 4 mg. This contract, which is non-competitive and competitively awarded without set-aside designation, carries a firm fixed price structure with an ultimate completion date of January 12, 2026. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under the parent entity Cencora, Inc., which operates under the AmerisourceBergen trade name and serves as a critical pharmaceutical distributor for federal healthcare systems.
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.9 million through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Ondansetron HCL is an antiemetic medication commonly used in military and veteran healthcare settings to manage nausea and vomiting. The contract award demonstrates AmerisourceBergen's continued capability to fulfill federal medical procurement requirements through open competition and serves the Defense Health Agency and other government healthcare systems under this flexible contract mechanism.
Quick answers
Who was awarded contract SPE2DR26F9KK8?
SPE2DR26F9KK8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F9KK8 worth?
The government has obligated $25,475 on SPE2DR26F9KK8.
Is contract SPE2DR26F9KK8 an order under another contract?
Yes. SPE2DR26F9KK8 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KK8 competed?
The extent of competition for SPE2DR26F9KK8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award